C
Crescent Biopharma, Inc. (CBIO)
15.16
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
15.16
0.00 (0.00%)
This stock has a consensus price target of $26.67 based on the ratings of 6 analysts. The high is $35.00 and the low is $22.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 22 | $ 26.67 | $ 35 |
| O’zgarish | 45.12% | 75.92% | 130.87% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-02 | 45.12% | HC Wainwright & Co. | $25 → $22 | Maintains | Buy |
| 2026-01-21 | 130.87% | Guggenheim | $35 | Initiates Coverage On | Buy |
| 2025-08-27 | 64.91% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy |
| 2025-08-25 | 71.5% | Jefferies | $26 | Initiates Coverage On | Buy |
| 2025-08-11 | 64.91% | HC Wainwright & Co. | $25 | Initiates Coverage On | Buy |